StreetInsider.com News Articles

Gemina Laboratories Strategic Update

Wed, 10 Jul 2024 09:00:00 -0400

ACCELERATING COMMERCIALISATION

VANCOUVER, BC / ACCESSWIRE / July 10, 2024 / Gemina Laboratories Ltd (CSE:GLAB)(OTCQB:GLABF)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide a strategic update and summary of progress in H1 2024. In our last strategic update in March the Company indicated a focus on developing multiple revenue streams, including product development, licenses, and services. We are pleased to report very positive progress on this with a number of commercial partners and the achievement of maiden commercial revenues, alongside an update on our new protein production facility, new products and capabilities, as

Gemina Laboratories Strategic Update

Wed, 10 Jul 2024 09:00:00 -0400

ACCELERATING COMMERCIALISATION

Gemina Laboratories Commences Trading on the OTCQB Market in the United States

Thu, 20 Jun 2024 13:00:00 -0400

Gemina Laboratories (OTCQB: GLABF), (CSE: GLAB), (FRA: 817) expands investor reach to U.S. by posting shares on OTCQB.

VANCOUVER, BC / ACCESSWIRE / June 20, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(OTCQB:GLABF)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce that it has qualified for trading on the OTCQB Venture Market in the United States operated by the OTC Markets Group Inc. and the Company's common shares have commenced trading today on the OTCQB under the symbol "GLABF." The Company's common shares will continue to trade on the CSE Exchange (the "CSE") under the

Gemina Laboratories Commences Trading on the OTCQB Market in the United States

Thu, 20 Jun 2024 13:00:00 -0400

Gemina Laboratories (OTCQB: GLABF), (CSE: GLAB), (FRA: 817) expands investor reach to U.S. by posting shares on OTCQB.